[
    [
        {
            "time": "2021-07-16",
            "original_text": "康泰生物成功分离德尔塔毒株，股价应声暴涨14%，专家：分离毒株并非难事",
            "features": {
                "keywords": [
                    "康泰生物",
                    "德尔塔毒株",
                    "分离",
                    "股价暴涨"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物成功分离德尔塔毒株，股价应声暴涨14%，专家：分离毒株并非难事",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-09",
            "original_text": "康泰生物：约296.57万股限售股8月10日解禁，占比0.43% 解禁",
            "features": {
                "keywords": [
                    "康泰生物",
                    "限售股",
                    "解禁"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物：约296.57万股限售股8月10日解禁，占比0.43% 解禁",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-29",
            "original_text": "全球新冠确诊病例超2亿！国药集团迎来重大发现！这家深圳公司也成功分离德尔塔变异株",
            "features": {
                "keywords": [
                    "全球确诊",
                    "国药集团",
                    "德尔塔变异株",
                    "深圳公司"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "全球新冠确诊病例超2亿！国药集团迎来重大发现！这家深圳公司也成功分离德尔塔变异株",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-20",
            "original_text": "本土新增62+32，又一机场发现阳性！全球确诊破2亿",
            "features": {
                "keywords": [
                    "本土新增",
                    "机场阳性",
                    "全球确诊"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "公共卫生",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "本土新增62+32，又一机场发现阳性！全球确诊破2亿",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-22",
            "original_text": "康泰生物高开8.1% “德尔塔”研发取得重要进展",
            "features": {
                "keywords": [
                    "康泰生物",
                    "高开",
                    "德尔塔",
                    "研发进展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物高开8.1% “德尔塔”研发取得重要进展",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]